111 (YI) Shares Outstanding (Diluted Average) (2017 - 2025)
111's (YI) quarterly Shares Outstanding (Diluted Average) came in at $24.5 million in Q4 2025, up 2.57% year-on-year from $23.9 million in Q4 2024, and down 85.92% quarter-over-quarter from $174.2 million in Q3 2025.
111 (YI) Shares Outstanding (Diluted Average) (2017 - 2025) Analysis & Trends
111 has disclosed Shares Outstanding (Diluted Average) across 9 years of filings, most recently posting $24.5 million for Q4 2025.
- Shares Outstanding (Diluted Average) for Q4 2025 came in at $24.5 million, up 2.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $24.5 million (up 2.57% YoY), and the FY2025 annual result was $24.2 million, up 1.26% from the prior year.
- Shares Outstanding (Diluted Average) came in at $24.5 million for Q4 2025 at 111, down from $174.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $174.2 million in Q3 2025 to a low of $23.4 million in Q3 2023.
- The 5-year median for Shares Outstanding (Diluted Average) is $24.4 million (2022), against an average of $39.4 million.
- Across the five-year window, Shares Outstanding (Diluted Average) declined 9.69% in 2022 and surged 626.19% in 2025, its largest moves.
- 111's Shares Outstanding (Diluted Average) stood at $25.9 million in 2021, then slipped by 9.69% to $23.4 million in 2022, then retreated by 0.05% to $23.4 million in 2023, then grew by 2.15% to $23.9 million in 2024, then climbed by 2.57% to $24.5 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $24.5 million (Q4 2025), $174.2 million (Q3 2025), and $24.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1.00 |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 124.10 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 195.38 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 236.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 116.06 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 37.48 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 24.54 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 47.09 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 14.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.54 Mn |
| Sep 30, 2025 | 174.22 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Mar 31, 2025 | 173.12 Mn |
| Dec 31, 2024 | 23.92 Mn |
| Sep 30, 2024 | 23.99 Mn |
| Jun 30, 2024 | 23.68 Mn |
| Mar 31, 2024 | 23.94 Mn |
| Dec 31, 2023 | 23.42 Mn |
| Sep 30, 2023 | 23.38 Mn |
| Jun 30, 2023 | 24.00 Mn |
| Mar 31, 2023 | 24.46 Mn |
| Dec 31, 2022 | 23.43 Mn |
| Sep 30, 2022 | 24.37 Mn |
| Jun 30, 2022 | 25.26 Mn |
| Mar 31, 2022 | 26.21 Mn |
| Dec 31, 2021 | 25.94 Mn |
| Sep 30, 2021 | 25.65 Mn |
| Jun 30, 2021 | 25.66 Mn |
| Mar 31, 2021 | 25.55 Mn |